Candida auris admission screening pilot in select units of New York City health care facilities, 2017-2019 - 19/07/23
, Elizabeth Dufort, MD, MPH a, Sudha Chaturvedi, PhD b, d, YanChun Zhu, MS b, Monica Quinn, MS, RN a, Coralie Bucher, MPH a, Richard Erazo, BS a, Valerie Haley, PhD a, d, Jiankun Kuang, MS a, Belinda Ostrowsky, MD, MPH a, c, Karen Southwick, MD, MSc a, Snigdha Vallabhaneni, MD, MPH c, Jane Greenko, MPH, RN a, Boldtsetseg Tserenpuntsag, DrPH a, Debra Blog, MD, MPH a, Emily Lutterloh, MD, MPH a, dHighlights |
• | Implemented Candida auris (C. auris) admission screening in health care facilities in New York City. |
• | Highest C. auris colonization rates in admissions to nursing home ventilator units. |
• | Admission screening can be part of a strategy to identify C. auris colonization. |
• | Identification is important to reduce transmission in high-risk settings. |
Abstract |
Background |
This pilot project implemented admission screening for Candida auris (C. auris) using real-time polymerase chain reaction (rt-PCR) in select high-risk units within health care facilities in New York City.
Methods |
An admission screening encounter consisted of collecting 2 swabs, to be tested by rt-PCR, and a data collection form for individuals admitted to ventilator units at 2 nursing homes (NHA and NHB), and the ventilator/pulmonary unit, intensive care unit, and cardiac care unit at a hospital (Hospital C) located in New York City from November 2017 to November 2019.
Results |
C. auris colonization was identified in 6.9% (n = 188/2,726) of admissions to participating units. Rates were higher among admissions to NHA and NHB (20.7% and 22.0%, respectively) than Hospital C (3.6%). Within Hospital C, the ventilator/pulmonary unit had a higher rate (5.7%) than the intensive care unit (3.8%) or cardiac care unit (2.5%).
Discussion |
Consistent with prior research, we found that individuals admitted to ventilator units were at higher risk of C. auris colonization.
Conclusions |
This project demonstrates the utility of admission screening using rt-PCR testing to rapidly identify C. auris colonization among admissions to health care facilities so that appropriate transmission-based precautions and control measures can be implemented rapidly to help decrease transmission.
Le texte complet de cet article est disponible en PDF.Key Words : Candida auris admission screening health care facility, Fungal, Colonization, Multidrug Resistance
Plan
| The pilot was supported by the emerging infections program cooperative agreement number 5U50CK000199 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services or the New York State Department of Health. |
|
| Conflicts of interest: None to report. |
|
| Previous presentation: Preliminary data were presented as a poster at ID Week in August 2018 (Presentation #384). |
|
| Availability of data statement: Due to the sensitive nature of the data collected in this pilot, facilities participated on the condition that facility names would not be released and were assured raw data would remain confidential and would not be shared. |
Vol 51 - N° 8
P. 866-870 - août 2023 Retour au numéro
Article précédent
- A comparative study on antibiotic resistance and virulence properties of Staphylococcus aureus isolated from hospitalized patients and hospital environment
- Sareh Kholaseh, Safoura Derakhshan, Masoumeh Abedini
- Antibacterial activity of silver nanoparticles functionalized with amikacin applied against multidrug-resistant acinetobacter baumannii
- Larissa de O. Camargo, Inglid Fontoura, Thaís S. Veriato, Leandro Raniero, Maiara L. Castilho
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?